ALGS vs REG · rev $3.6M vs P/E 34, $12.93B cap
Aligos Therapeutics Inc (ALGS) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
REG does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ALGS and REG stock pages for the full models.
Not investment advice.